These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
407 related articles for article (PubMed ID: 19540871)
21. Absence of cytogenetic effects in children and adults with attention-deficit/hyperactivity disorder treated with methylphenidate. Ponsa I; Ramos-Quiroga JA; Ribasés M; Bosch R; Bielsa A; Ordeig MT; Morell M; Miró R; de Cid R; Estivill X; Casas M; Bayés M; Cormand B; Hervás A Mutat Res; 2009 Jun; 666(1-2):44-9. PubMed ID: 19457516 [TBL] [Abstract][Full Text] [Related]
22. Methylphenidate regulates c-fos and fosB expression in multiple regions of the immature rat brain. Chase TD; Carrey N; Brown RE; Wilkinson M Brain Res Dev Brain Res; 2005 Apr; 156(1):1-12. PubMed ID: 15862622 [TBL] [Abstract][Full Text] [Related]
23. No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapy. Walitza S; Kämpf K; Artamonov N; Romanos M; Gnana Oli R; Wirth S; Warnke A; Gerlach M; Stopper H Toxicol Lett; 2009 Jan; 184(1):38-43. PubMed ID: 19015014 [TBL] [Abstract][Full Text] [Related]
28. OROS methylphenidate for the treatment of adults with attention-deficit/hyperactivity disorder. Ramos-Quiroga JA; Corominas M; Castells X; Bosch R; Casas M Expert Rev Neurother; 2009 Aug; 9(8):1121-31. PubMed ID: 19673602 [TBL] [Abstract][Full Text] [Related]
29. Chronic oral methylphenidate administration to periadolescent rats yields prolonged impairment of memory for objects. LeBlanc-Duchin D; Taukulis HK Neurobiol Learn Mem; 2007 Oct; 88(3):312-20. PubMed ID: 17544718 [TBL] [Abstract][Full Text] [Related]
30. Object memory impairment at post-drug Day 15 but not at Day 1 after a regimen of repeated treatment with oral methylphenidate. Taukulis HK; Bigney EE; Fry MD; Hooper C Neurosci Lett; 2014 Apr; 566():252-6. PubMed ID: 24631430 [TBL] [Abstract][Full Text] [Related]
31. Different adaptations in ventral tegmental area dopamine neurons in control and ethanol exposed rats after methylphenidate treatment. Shen RY; Choong KC Biol Psychiatry; 2006 Apr; 59(7):635-42. PubMed ID: 16199009 [TBL] [Abstract][Full Text] [Related]
32. Integrating the open field, elevated plus maze and light/dark box to assess different types of emotional behaviors in one single trial. Ramos A; Pereira E; Martins GC; Wehrmeister TD; Izídio GS Behav Brain Res; 2008 Nov; 193(2):277-88. PubMed ID: 18590774 [TBL] [Abstract][Full Text] [Related]
33. Short-term effects of adolescent methylphenidate exposure on brain striatal gene expression and sexual/endocrine parameters in male rats. Adriani W; Leo D; Guarino M; Natoli A; Di Consiglio E; De Angelis G; Traina E; Testai E; Perrone-Capano C; Laviola G Ann N Y Acad Sci; 2006 Aug; 1074():52-73. PubMed ID: 17105903 [TBL] [Abstract][Full Text] [Related]
34. Misinterpreting emotional expressions in attention-deficit/hyperactivity disorder: evidence for a neural marker and stimulant effects. Williams LM; Hermens DF; Palmer D; Kohn M; Clarke S; Keage H; Clark CR; Gordon E Biol Psychiatry; 2008 May; 63(10):917-26. PubMed ID: 18272140 [TBL] [Abstract][Full Text] [Related]
35. Differential pharmacokinetics and pharmacodynamics of methylphenidate enantiomers: does chirality matter? Markowitz JS; Patrick KS J Clin Psychopharmacol; 2008 Jun; 28(3 Suppl 2):S54-61. PubMed ID: 18480678 [TBL] [Abstract][Full Text] [Related]
36. [Effectiveness of oral osmotic-methylphenidate in treatment of attention deficit hyperactivity disorder in children]. Pan XX; Ma HW; Wan B; Dai XM Zhongguo Dang Dai Er Ke Za Zhi; 2008 Aug; 10(4):471-4. PubMed ID: 18706164 [TBL] [Abstract][Full Text] [Related]
37. Effects of acute and chronic methylphenidate on delay discounting. Slezak JM; Anderson KG Pharmacol Biochem Behav; 2011 Oct; 99(4):545-51. PubMed ID: 21669219 [TBL] [Abstract][Full Text] [Related]
38. DNA damage in rats after treatment with methylphenidate. Andreazza AC; Frey BN; Valvassori SS; Zanotto C; Gomes KM; Comim CM; Cassini C; Stertz L; Ribeiro LC; Quevedo J; Kapczinski F; Berk M; Gonçalves CA Prog Neuropsychopharmacol Biol Psychiatry; 2007 Aug; 31(6):1282-8. PubMed ID: 17614179 [TBL] [Abstract][Full Text] [Related]
39. Flow cytometric detection of Pig-A mutant red blood cells using an erythroid-specific antibody: application of the method for evaluating the in vivo genotoxicity of methylphenidate in adolescent rats. Dobrovolsky VN; Boctor SY; Twaddle NC; Doerge DR; Bishop ME; Manjanatha MG; Kimoto T; Miura D; Heflich RH; Ferguson SA Environ Mol Mutagen; 2010 Mar; 51(2):138-45. PubMed ID: 19658152 [TBL] [Abstract][Full Text] [Related]
40. Cytogenetic assessment of methylphenidate treatment in pediatric patients treated for attention deficit hyperactivity disorder. Tucker JD; Suter W; Petibone DM; Thomas RA; Bailey NL; Zhou Y; Zhao Y; Muniz R; Kumar V Mutat Res; 2009; 677(1-2):53-8. PubMed ID: 19465145 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]